Table 2.
Association between NONHSAT076754 expression and clinicopathological factors in 70 EOC patients.
| Variable | Low NONHSAT076754 expression (n=35) | High NONHSAT076754 expression (n=35) | P-value | |
|---|---|---|---|---|
| n(%) | n(%) | |||
| Age (years) | ||||
| <50 | 18 (51.4) | 11 (31.4) | ||
| ≥50 | 17 (48.6) | 24 (68.6) | 0.090 | |
| Histological subtype | ||||
| Serous | 28 (80.0) | 22 (62.9) | ||
| Others | 7 (20.0) | 13 (37.1) | 0.112 | |
| Tumor grade | ||||
| Low | 13 (37.1) | 5 (14.3) | ||
| High | 22 (62.9) | 30 (85.7) | 0.029 | |
| FIGO Stage | ||||
| I-II | 12 (34.3) | 4 (11.4) | ||
| III-IV | 23 (65.7) | 31 (88.6) | 0.023 | |
| Residual tumor diameter (cm) | ||||
| <1 | 24 (68.6) | 21 (60.0) | ||
| ≥1 | 11 (31.4) | 14 (40.0) | 0.454 | |
| Lymph node metastasis | ||||
| Absent | 21 (60.0) | 7 (20.0) | ||
| Present | 14 (40.0) | 28 (80.0) | <0.001 | |
| CA125 level (U/ml) | ||||
| <600 | 16 (45.7) | 14 (40.0) | ||
| ≥600 | 19 (54.3) | 21 (60.0) | 0.629 | |
| Ascites | ||||
| <100 | 18 (51.4) | 21 (60.0) | ||
| ≥100 | 17 (48.6) | 14 (40.0) | 0.470 | |
| Distant metastasis | ||||
| Absent | 33 (94.3) | 28 (80.0) | ||
| Present | 2 (5.7) | 7 (20.0) | 0.074 | |